Liu S, Ruan Y, Chen X, He B, Chen Q
Front Cell Dev Biol. 2024; 12:1427724.
PMID: 39247624
PMC: 11377224.
DOI: 10.3389/fcell.2024.1427724.
Sumaira S, Vijayarathna S, Hemagirri M, Adnan M, Hassan M, Patel M
Noncoding RNA Res. 2024; 9(4):1140-1158.
PMID: 39022680
PMC: 11250886.
DOI: 10.1016/j.ncrna.2024.06.003.
Messina S
Mol Biol Rep. 2024; 51(1):531.
PMID: 38637419
PMC: 11026240.
DOI: 10.1007/s11033-024-09439-z.
Pagoni M, Cava C, Sideris D, Avgeris M, Zoumpourlis V, Michalopoulos I
J Pers Med. 2023; 13(11).
PMID: 38003902
PMC: 10672431.
DOI: 10.3390/jpm13111586.
Cornejo M, Linz T
Anal Chim Acta. 2023; 1275:341605.
PMID: 37524470
PMC: 10390710.
DOI: 10.1016/j.aca.2023.341605.
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges.
Hussen B, Rasul M, Abdullah S, Hidayat H, Faraj G, Ali F
Mil Med Res. 2023; 10(1):32.
PMID: 37460924
PMC: 10351202.
DOI: 10.1186/s40779-023-00468-6.
Air Pollution and microRNAs: The Role of Association in Airway Inflammation.
Furci F, Allegra A, Tonacci A, Isola S, Senna G, Pioggia G
Life (Basel). 2023; 13(6).
PMID: 37374157
PMC: 10304259.
DOI: 10.3390/life13061375.
MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?.
Yang H, Liu Y, Chen L, Zhao J, Guo M, Zhao X
Biomolecules. 2023; 13(6).
PMID: 37371458
PMC: 10295928.
DOI: 10.3390/biom13060877.
Inhibition of RNA-binding proteins with small molecules.
Wu P
Nat Rev Chem. 2023; 4(9):441-458.
PMID: 37127961
DOI: 10.1038/s41570-020-0201-4.
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.
Fariha A, Hami I, Tonmoy M, Akter S, Al Reza H, Bahadur N
Heliyon. 2022; 8(10):e11081.
PMID: 36303933
PMC: 9593298.
DOI: 10.1016/j.heliyon.2022.e11081.
Prognostic value of micro-RNA 375, 133, 143, 145 in esophageal carcinoma: A systematic review and meta-analysis.
Fang P, Zhou J, Li X, Luan S, Xiao X, Shang Q
Front Oncol. 2022; 12:828339.
PMID: 36176382
PMC: 9513119.
DOI: 10.3389/fonc.2022.828339.
Activating transcription factor 4-dependent hsa-miR-663a transcription mediates mTORC1/p70S6K1 signaling underleucine deprivation.
Yamamura J, Ma S, Jia H, Kato H
Front Nutr. 2022; 9:965771.
PMID: 35990342
PMC: 9389164.
DOI: 10.3389/fnut.2022.965771.
Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases.
Saiyed A, Vasavada A, Johar S
Futur J Pharm Sci. 2022; 8(1):24.
PMID: 35382490
PMC: 8972743.
DOI: 10.1186/s43094-022-00413-9.
Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review.
Md S, Alhakamy N, Karim S, Gabr G, Iqubal M, Murshid S
Pharmaceutics. 2021; 13(12).
PMID: 34959401
PMC: 8708027.
DOI: 10.3390/pharmaceutics13122120.
miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin's Lymphoma: Moving towards an RNA-Guided Precision Medicine.
Fernandes M, Marques H, Teixeira A, Medeiros R
Cancers (Basel). 2021; 13(24).
PMID: 34944942
PMC: 8699447.
DOI: 10.3390/cancers13246324.
Critical role of backbone coordination in the mRNA recognition by RNA induced silencing complex.
Zhu L, Jiang H, Cao S, Unarta I, Gao X, Huang X
Commun Biol. 2021; 4(1):1345.
PMID: 34848812
PMC: 8632932.
DOI: 10.1038/s42003-021-02822-7.
A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma.
Perri P, Ponzoni M, Corrias M, Ceccherini I, Candiani S, Bachetti T
Cancers (Basel). 2021; 13(21).
PMID: 34771690
PMC: 8582685.
DOI: 10.3390/cancers13215528.
Aberrant Post-Transcriptional Regulation of Protein Expression in the Development of Chronic Obstructive Pulmonary Disease.
Aloufi N, Alluli A, Eidelman D, Baglole C
Int J Mol Sci. 2021; 22(21).
PMID: 34769392
PMC: 8584689.
DOI: 10.3390/ijms222111963.
MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia.
Alyami N
Front Oncol. 2021; 11:717759.
PMID: 34760689
PMC: 8573223.
DOI: 10.3389/fonc.2021.717759.
The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness.
Ma Y, Shen N, Wicha M, Luo M
Cells. 2021; 10(9).
PMID: 34572067
PMC: 8469079.
DOI: 10.3390/cells10092415.